{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2Fclinical-assessment-in-alzheimers-disease-part-1-december-2021-dmtNFcQT","width":444,"version":"1.0","type":"rich","title":"260 - Clinical Assessment in Alzheimer's Disease Part 1: December 2021","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/576560ba-955b-46e3-afd8-6ba108a469ce/slide10-2.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/10758764-34c4-49df-ba3d-4673205c2ece\" height=\"200\" width=\"100%\" title=\"260 - Clinical Assessment in Alzheimer&apos;s Disease Part 1: December 2021\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Can smell, gaze, blinking rate, or handwriting offer a window into what happens inside the Alzheimer’s disease brain? Are there parameters we can add to our batteries for assessing cognitive decline in a clinical setting? Missed opportunities in cognitive assessment? Maybe. This episode is dedicated to all kinds of variables that can help orient ourselves on the Alzheimer’s disease continuum, and perhaps predict the progression from MCI to AD.  \n\nSections in this episode:  \nNon-Cognitive Variables (6.27)  \nCognitive Variables (20.28) "}